Skip to content

Peppermint Herbal Tea Study on Overall Digestion

Efficacy and Tolerability of Pure Peppermint Herbal Tea on Overall Digestion in Healthy Adults: A Randomized-Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093141
Enrollment
60
Registered
2025-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Pure Peppermint Herbal Tea: Serving Size- 2g in 150 ml hot water, brewing time ? 5 mins in about to boil water temp. Recommended consumption: One cup of Pure Peppermint Herbal Tea twice

Sponsors

Luxmi Tea Co Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy adults, both males and females, aged 18 to 65 years, inclusive Generally healthy individuals, as determined by medical history and physical examination Experiencing occasional digestive discomfort bloating, gas, indigestion, abdominal discomfort, altered bowel habits, dyspepsia with little or no pain at least once a week for the past one month before screening Stable health status for at least 3 months before screening visit Willing and able to provide written informed consent before any study related procedures. This ensures that participants understand the study purpose, procedures, risks, and benefits and that their participation is voluntary Participants must be daily tea taker, willing and able to comply with all study procedures, including daily consumption of the assigned tea Pure Peppermint Herbal Tea or Normal tea prepared as per direction provided and continuing for the duration of the study, attending scheduled study visits, and completing all required questionnaires and subject diaries. Access to a telephone and the ability to be contacted by study personnel Ability to communicate effectively with study personnel Agreement to maintain a stable diet throughout the study period Day 0 to 8 weeks and not undertake any major dietary changes Agreement to refrain from starting any new exercise programs or significantly altering physical activity levels during the study period Willingness to abstain from other herbal supplements, teas, or digestion improvement programs during the study period

Exclusion criteria

Exclusion criteria: Diagnosis or history of any chronic gastrointestinal disorder, including but not limited to irritable bowel syndrome IBS, inflammatory bowel disease IBD Crohns disease, ulcerative colitis, celiac disease, gastroesophageal reflux disease GERD requires continuous treatment, chronic constipation or diarrhoea, known gastrointestinal motility disorders History of major gastrointestinal surgery excluding appendectomy or cholecystectomy that could significantly alter digestive function Use of prescription medications for digestive health within 2 weeks before screening, including Proton pump inhibitors PPIs, H2 receptor antagonists, Antacids regular, chronic use, Laxatives regular, chronic use, Antidiarrheals regular, chronic use, Prokinetics, Digestive enzymes and Antibiotics Known allergy or sensitivity to peppermint or related plants other members of the Lamiaceae family Pregnant or breastfeeding women, or women planning to become pregnant during the study period Participation in another clinical trial or intervention study within 30 days before screening Uncontrolled diabetes, cardiovascular disease, renal or hepatic impairment, autoimmune disorders, and active infections History of alcohol or substance abuse that, in the opinion of the investigator, could interfere with study compliance or data interpretation. Presence of any unstable psychiatric condition that, in the opinion of the investigator, could interfere with study compliance or data interpretation History of recent or active infectious illnesses common cold, influenza, gastroenteritis within 2 weeks before screening

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Pure Peppermint Herbal Tea in improving overall digestion compared to normal teaTimepoint: Baseline and 8 weeks

Secondary

MeasureTime frame
To assess the frequency of bowel movements and stool consistency in two treatment groups To evaluate the safety and tolerability of Pure Peppermint Herbal Tea compared to normal teaTimepoint: Baseline and 8 weeks

Countries

India

Contacts

Public ContactSushavan Sinha

Luxmi Tea Co Private Limited

sushavan@luxmigroup.in9609978633

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026